Veterinary Vaccines Market Growth, Global Survey, Analysis, Share, Company Profiles and Forecast by 2027

Comments · 159 Views

The Veterinary Vaccines research report also includes an insightful study of the prominent players of the industry along with their business overview, strategic planning, and business expansion plans adopted by them.

The Veterinary Vaccines research report also includes an insightful study of the prominent players of the industry along with their business overview, strategic planning, and business expansion plans adopted by them. This assists the readers and business owners in formulating strategic expansion and investment plans. The report focuses on mergers and acquisitions, joint ventures, collaborations, partnerships, corporate and government deals, and others. The report also talks about the expansions these prominent players are vying for in the key regions of the market. The report focuses on the detailed analysis of the technological and product developments undertaken by these companies.

The latest research report serves as a perfect example of the precise analysis of the global Veterinary Vaccines market. It includes the ToC, list of tables and figures, research methodology, geographic segmentation, competitive landscape, future developments, and technological innovation. Moreover, the report offers the latest coverage of the massive impact of the COVID-19 pandemic on the worldwide Veterinary Vaccines industry. The globally-disrupting incidence has impacted nearly every aspect of this business domain. However, the latest study expounds on the present market scenario and forecasts the pandemic’s aftermath, with respect to this industry. Furthermore, the major aspects of the market have been discussed in the report, with expert opinions on the current status of the market.

 

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/veterinary-vaccines-market

 

Key Highlights of Report

  • In January 2020, Automazioni VX, Inc. entered into a cooperative agreement with Merck Animal Health, a division of Merck KGaA. The collaboration was aimed to launch Innoject Pro, a uniquely developed technology for subcutaneous injection vaccination of chicken. The technology can be utilized in conjunction with the Innovax vaccine by Merck Animal Health, which is used to safeguard poultry from bacterial infections.
  • The poultry segment is expected to lead the global veterinary vaccines market throughout the forecast period, expanding at a CAGR of 7.0%. The increased need for risk-free pet food, associated with a growing focus on developing new animal protection approaches, is estimated to drive the segment during the forecast period.
  • The injection segment is projected to retain the largest market share throughout the forecast period. Growth of the segment is attributable to increasing use of injection vaccines for protection of animal health. Injection vaccines play a crucial role in preventing and controlling the dissemination of disease outbreaks in both farm animals and livestock.

Market Overview:

The research report on the Veterinary Vaccines market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Veterinary Vaccines business sphere.

Some major companies operating in the global market include Kerry Group, BASF SE, Cargill Inc., Evonik Industries AG, Clariant AG, AkzoNobel NV, Ingredion Inc., Solvay SA, Archer Daniels Midland Company, and Royal DSM.

Emergen Research has segmented the global veterinary vaccines market based on type, administration path, technology, infection, and region.

  • Type Outlook (Revenue, USD Billion; 2017–2027)
    • Poultry
    • Swine
    • Aquaculture
    • Cattle
    • Cat
    • Dog
  • Administration Path Outlook (Revenue, USD Billion; 2017–2027)
    • Oral
    • Injection
    • Spray/Immersion
  • Technology Outlook (Revenue, USD Billion; 2017–2027)
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Toxoid
  • Infection Outlook (Revenue, USD Billion; 2017–2027)
    • Fungal
    • Bacterial
    • Parasitic
    • Viral
  • Regional Outlook (Revenue, USD Billion; 2017–2027)
    • North America
      1. S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

 

 

 

 

Comments